The College has established four awards which are given for outstanding contributions to the field of neuropsychopharmacology. These are the Heinz Lehmann Award, the Young Investigator Award, the Innovations in Neuropsychopharmacology Award and the CCNP Medal. Regulations regarding these awards, nomination and selection procedures are given here.

HEINZ LEHMANN AWARD
YOUNG INVESTIGATOR AWARD
INNOVATIONS IN NEUROPSYCHOPHARMACOLOGY
    RESEARCH AWARD
CCNP MEDAL
JOCK CLEGHORN AWARD

HEINZ LEHMANN AWARD

For Outstanding Contributions to Neuropsychopharmacology

The Heinz Lehmann Award is designed to recognize outstanding contributions by a single individual in the field of research in neuropsychopharmacology in Canada. The Award consists of $2,000 honorarium, a $1,000 travel award for the recipient to attend the CCNP Annual Meeting and a suitably engraved plaque. The Heinz Lehmann Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in the view of the Awards Committee, no qualified nominee.

Eligibility shall include individuals from academic institutions, foundations, governmental, industrial and research organizations, regardless of age or sex. The decision of the Awards Committee shall be based on originality and uniqueness of approach to clinical or laboratory research that had led to new, significant neuropsychopharmacological knowledge of concepts, or to the development of new therapeutic agents for the treatment of mental diseases. This should be evidenced by contributions based either on a specific piece of research or on a large body of neuropsychopharmacological research done over a period of years. The Awardee is expected to give a lecture based on his/her research at the Annual Meeting of the CCNP, and to contribute a manuscript based on the lecture to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

Read the 2002 CCNP Heinz Lehmann Award Paper by Dr. Howard Steiger:

Nomination for 2013 Heinz Lehmann Award

The names of nominees should be received by Dr. Paul Albert by November 30th, 2012. Supporting documentation must be received by December 31st, 2012. For each award, this documentation shall consist of:

1. A completed Heinz Lehmann Award checklist, signed by the nominee.
2. A two-page summary prepared by the sponsor describing the nominee's work and its importance in furthering the field of neuropsychopharmacology.
3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee's work.
4. The nominee's curriculum vitae.
5. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Heinz Lehmann Research Award may be given for basic research or clinical research in alternate years. The 2013 Award will be presented for basic research.

Please send the name of the nominee and a short supporting letter to:

Dr. Paul Albert
CCNP President

Please send one copy of the above electronically to Dr. Albert at palbert@uottawa.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2012.

YOUNG INVESTIGATOR AWARD

For Outstanding Contributions to Neuropsychopharmacology
by a Young Investigator

The Young Investigator Award is designed to recognize outstanding contributions in the field of research in neuropsychopharmacology by an individual young basic scientist or clinical investigator in Canada. Applications will be judged primarily on the basis of the candidate's work as an independent investigator. The Award consists of a $2,000 honorarium, a $1,000 travel award for costs related to the annual CCNP meeting, and a suitably engraved plaque. The Young Investigator Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in the view of the Awards Committee, no qualified nominee.

The major selection criterion is that the candidate be actively engaged in high quality neuropsychopharmacological research in Canada. There is no restriction concerning the field in which nominees have obtained their doctoral degree, but not more than ten years should have elapsed since the completion of their post-doctoral training (for example, PhD or residency) by July of the year of presentation. It is not required that the candidates be members of the College or have an academic appointment. The Awardee is expected to give a lecture based on his/her research at the Annual Meeting of the CCNP, and to contribute a manuscript based on the lecture to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

Nomination for 2013 CCNP Young Investigator Award

The names of nominees should be received by Dr. Paul Albert by November 30th, 2012. Supporting documentation must be received by December 31st, 2012. For each award, this documentation shall consist of:

1. A completed Young Investigator Award Cover Sheet, signed by the nominee.
2. A two-page summary prepared by the sponsor describing the nominee's work and its importance in furthering the field of neuropsychopharmacology.
3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee's work.
4. The nominee's curriculum vitae.
5. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Young Investigator Award is given for basic research or clinical research in alternate years. The 2013 Award will be presented for clinical research.

Please send the name of the nominee and a short supporting letter to:

Dr. Paul Albert
CCNP President

Please send one copy of the above electronically to Dr. Albert at palbert@uottawa.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2012.

INNOVATIONS IN NEUROPSYCHOPHARMACOLOGY RESEARCH AWARD

For Outstanding Innovations in Neuropsychopharmacology by an Individual or Group

Sponsored by Pfizer Canada Inc.

The Innovations in Neuropsychopharmacology Research Award is designed to recognize innovative research in neuropsychopharmacology. The Award consists of $5,000 and a suitably engraved plaque. The Innovations in Neuropsychopharmacology Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in view of the Awards Committee, no qualified nominee.

The decision of the Awards Committee will be based solely on the outstanding innovative nature of the work by an individual or a group as demonstrated by a single piece of research contributed over a number of years. The Awardee(s) is/are expected to give a lecture based on his/her/their research at the Annual Meeting of the CCNP, and to contribute a manuscript, based on the lecture, to the CCNP official journal, the Journal of Psychiatry & Neuroscience, not later than six months after the lecture.

Nomination for 2013 Innovations in Neuropsychopharmacology Research Award

The names of nominees should be received by Dr. Paul Albert by November 30th, 2012. Supporting documentation must be received by December 31st, 2012. For each award, this documentation shall consist of:

1. A completed CCNP Innovations Award checklist, signed by the nominee.
2. A two-page summary prepared by the sponsor describing the nominee's work and its importance in furthering the field of neuropsychopharmacology.
3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee's work.
4. The nominee's curriculum vitae.
5. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Innovations in Neuropsychopharmacology Research Award may be given for basic research or clinical research in alternate years. The 2013 Award will be presented for basic research.

Please send the name of the nominee and a short supporting letter to:

Dr. Paul Albert
CCNP President

Please send one copy of the above electronically to Dr. Albert at palbert@uottawa.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2012.

CCNP MEDAL

This Award was established to honour individuals for a meritorious career in, and outstanding contribution to, neuropsychopharmacology in Canada as evidenced by their activities in education, administration and/or patient care. Achievement in research is not a necessary criterion for this Award. An outstanding contribution implies achievement at the national or international level, and evidence of novel initiatives.

The Award, which does not have to be awarded each year, consists of a bronze medal engraved with the name of the recipient.

Nomination for 2013 CCNP Medal

The names of nominees should be received by Dr. Paul Albert by November 30th, 2012. Supporting documentation must be received by December 31st, 2012. For each award, this documentation shall consist of:

1. A completed CCNP Medal checklist, signed by the nominee.
2. A two-page summary prepared by the sponsor describing the nominee's work and its importance in furthering the field of neuropsychopharmacology.
3. The nominee's curriculum vitae and list of publications.
4. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Please send the name of the nominee and a short supporting letter to:

Dr. Paul Albert
CCNP President

Please send one copy of the above electronically to Dr. Albert at palbert@uottawa.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2012.

JOCK CLEGHORN AWARD

For Best Poster Presentation by a Research Trainee
Donated by the CCNP

This prize, which will consist of a cheque for $500, will be awarded by the CCNP for the best poster presentation by a research trainee (graduate student or clinical resident) at the Annual Meeting of the CCNP. All trainees/students who submit a poster presentation for the Annual Meeting will be eligible for this prize. Those already applying for travel bursaries will automatically be considered for the Jock Cleghorn Prize.

The poster presentations will be judged at the Annual Meeting by a committee consisting of at least 3 members of the Awards Committee (or substitute judges to be chosen by the Council from the CCNP membership if Awards Committee members are unable to attend the Annual Meeting). Topics on either basic or clinical aspects of neuropsychopharmacology will be considered. The poster should represent research in which the graduate student or resident is the primary investigator, and (s)he should be the first author of the submitted abstract. The winner of the award will be announced in the first Newsletter following the Annual Meeting.

---

COLLÉGE CANADIEN DE NEUROPSYCHOPHARMACOLOGIE
PRIX ET DISTINCTIONS

Quatre prix ont été institués par le Collège afin de reconnaître les contributions exceptionnelles des chercheurs canadiens dans le domaine de la neuropsychopharmacologie. Ces prix et distinctions sont le prix Heinz Lehmann, le prix Jeune Chercheur, le prix pour Innovation en recherche en neuropsychopharmacologie et la Médaille du CCNP. Les règlements concernant ces prix, les procédures de nominations et de sélection sont décrits dans les sections ici.

PRIX HEINZ LEHMANN
PRIX JEUNE CHERCHEUR
PRIX POUR INNOVATION EN RECHERCHE
    EN NEUROPSYCHOPHARMACOLOGIE
MÉDAILLE DU CCNP
PRIX JOCK CLEGHORN

PRIX HEINZ LEHMANN

Pour contributions exceptionnelles en neuropsychopharmacologie

Le Prix Heinz Lehmann veut reconnaître l'excellence des rechercheurs canadiens en neuropsychopharmacologie. Le prix inclut une bourse de 5000,00$ et une plaque commémorative.

Ce prix sera attribué pour des travaux de recherche effectués surtout au Canada par des scientifiques canadiens. Sont éligibles les individus oeuvrant dans les institutions académiques, gouvernementales ou dans les industries, les fondations et centres de recherche et ce, sans égard à l'âge et au sexe. Le choix du Comité des Prix et Distinctions devra être basé soit a) sur l'originalité et l'approche utilisée en recherche clinique ou fondamentale, qui a conduit au dévelopment de nouveaux concepts et/ou nouvelles connaissances importantes en neuropsychopharmacologie, soit b) sur la mise-au-point de nouveaux produits ou approches thérapeutiques pour le traitement de maladies mentales. L'attribution de ce prix doit être justifiée par une contribution exceptionnelle à un domaine précis de recherche ou par l'ensemble des travaux de recherche en neuropsychopharmacologie effectués sur une période de plusieurs années.

2002 CCNP Heinz Lehmann Award Paper pour Dr. Howard Steiger:

PRIX JEUNE CHERCHEUR

Pour contributions exceptionnelles en neuropsychopharmacologie par un Jeune Chercheur

Le prix Jeune Chercheur veut reconnaître l'excellence de jeunes rechercheurs canadiens (recherche clinique ou fondamentale) en neuropsychopharmacologie. Le prix inclut une bourse de 2500,00$, et subvention de recherche de 2000,00$ plus une plaque commémorative.

Le principal critère de sélection est basé sur la démonstration que le candidat est actif et engagé, au Canada, dans une recherche en neuropsychopharmacologie de qualité exceptionnelle. Pour être éligible, un candidat ne doit pas avoir terminé son Ph.D. ou sa résidence depuis plus de 10 ans, et ce en juillet de l'année de l'obtention du prix. Tous les domaines de recherches spécialisées (Ph.D.) ou résidence sont éligibles. Il n'est pas nécessaire que le candidat soit membre du Collège ou qu'il soit détenteur d'un poste universitaire. Ce prix est toutefois accordé pour des recherches effectuées avant tout au Canada par un scientifique canadien.

PRIX POUR INNOVATION EN RECHERCHE EN NEUROPSYCHOPHARMACOLOGIE

Don de Pfizer Canada Inc.

Pour une innovation exceptionnelle en recherche en neuropsychopharmacologie par un groupe ou un individu

Le prix de l'innovation en recherche en neuropsychopharmacologie sera présenté chaque année pour une oeuvre réalisée principalement au Canada, par un(des) scientifique(s) canadien(s), à moins que le comité de sélection ne soit d'avis qu'il n'existe aucun candidat qualifié. La décision du comité de sélection se fondera uniquement sur la nature novatrice du travail d'un individu ou d'un groupe, tel que démonté par un projet spécifique ou encore un ensemble de projets s'échelonnant sur plusieurs années. Un montant de 5000,00$ ainsi qu'une plaque gravée seront présentés chaque année pour marquer une innovation exceptionnelle en ce qui a trait à la recherche en sciences de base ou clinique.

MÉDAILLE DU CCNP

Ce prix veut reconnaître et honorer certains individus pour leur carrière exemplaire et pour une contribution exceptionnelle dans le domaine de la neuropsychopharmacologie au Canada, ceci étant démontré par des activités en éducation et formation, en administration et/ou dans l'amélioration des soins aux patients. Une performance exceptionnelle en recherche n'est pas un critère essentiel dans l'attribution de ce prix. Cette distinction inclut une médaille de bronze gravée au nom du récipiendaire.

Procédure de mise en candidature et exigences:

Les mises en candidature pour ces prix et distinctions devraient être soumises au bureau du Président du CCNP avant le premier décembre de l'année précédant l'attribution des Prix. Le dossier de mise en candidature doit inclure:

1. Six copies d'un résumé de deux pages, préparé par le parrain, décrivant les travaux du candidat et l'importance de ceux-ci pour l'avancement dela neuropsychopharmacologie.
2. Six copies de tirés à part et de manuscrits considérés par le parrain comme étant particulièrement pertinents et démontrant la qualité exceptionnelle des travaux du candidat.
3. Six copies du curriculum vitae et de la liste des publications du candidat.
4. Six copies d'un résumé de la biographie du candidat préparée par le parrain.

La présententation officielle des prix et distinctions sera faite lors du congrès annuel du Collèges.

PRIX JOCK CLEGHORN

Pour la meilleure presentation par affiche d'un rechercheur en formation Attibuté por le CCNP

Ce prix, qui consiste en une plaque commemorative gravei et un cheque de 500.00$ sera decerne por le CCNP à la meilleur presentation par affiche d'un rechercheur en formation (etudiant gradué ou resident clinique) lors du meeting annuel du CCNP. Les candidats sonhutant sonnettreat leur affiche à ce concours devront envoyer une lettre d'introduction et leur resumé au president du CCNP avant le 31 mars.

Les presentations d'affiches seront juges lors du congres annuel par un comité constitué d'au moins 3 membres du comité des prix (ou jurés remplaçant choisis auprés conseil des membres du CCNP in les membres du comité des prix sont dans l'impossibilité d'amiter à la rencontre annuelle les aspect fondamentaux et cliniques de la neuropsychopharmacologie seront pris en consideration. l'affiche d representer une red pour laquelle l'etudiant gradué ou le resident est le principal investigateur et il/elle doit ètre l'auteur majeur du resumé sonn... le gagnant du prix sera proclaimé le premier bulletin a prix la rencontre annuelle.